Utama › Mielofibrosis › Florida › Miami
Kajian klinikal Mielofibrosis di Miami, FL
10 kajian untuk Mielofibrosis sedang mencari peserta di lokasi dalam dan sekitar Miami (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Mengambil pesertaFasa 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Mengambil pesertaFasa 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Mengambil pesertaFasa 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Mengambil pesertaFasa 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Mengambil pesertaFasa 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Mengambil pesertaFasa 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Mengambil pesertaFasa 3
- University of Miami, Miami
Kajian Mielofibrosis di bandar lain
- Houston, TX19 kajian
- New York City, NY18 kajian
- Boston, MA12 kajian
- Durham, NC12 kajian
- Columbus, OH11 kajian
- Seattle, WA11 kajian
- Salt Lake City, UT10 kajian
- Nashville, TN9 kajian
- Cleveland, OH9 kajian
- Tampa, FL9 kajian
- Atlanta, GA9 kajian
- Baldwin Park, CA9 kajian
Kajian lain di Miami
- Kanser Payudara42 kajian
- Kanser (semua jenis)36 kajian
- Kanser Paru-paru Bukan Sel Kecil31 kajian
- Kanser Prostat27 kajian
- Obesiti27 kajian
- Leukemia Mieloid Akut24 kajian
- Kanser Metastatik24 kajian
- Kanser Ovari23 kajian
- Berat Badan Berlebihan23 kajian
- Mieloma Pelbagai21 kajian
- Kolitis Ulseratif21 kajian
- Penyakit Alzheimer20 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.